ADARx Pharmaceuticals, Inc. carries a market capitalization of 1.87B, placing it among publicly traded companies globally.
| Market Cap | 1.87B |
| Enterprise Value | N/A |
ADARx Pharmaceuticals, Inc.'s stock has declined approximately -5.68475% over the past 52 weeks. The 50-day moving average sits at 19.91, while the 200-day moving average is 19.91.
| Beta (5Y) | N/A |
| 52-Week Price Change | -5.68475% |
| 50-Day Moving Average | 19.91 |
| 200-Day Moving Average | 19.91 |
| Average Volume (20 Days) | N/A |